导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -1.50% | 2644/4773 |
| 近一周 | -1.14% | 348/5462 |
| 近一月 | -1.76% | 1032/5421 |
| 近一季 | -4.97% | 1739/5209 |
| 近半年 | -2.73% | 1999/4920 |
| 近一年 | 0.10% | 2638/4366 |
| 近两年 | 33.09% | 2155/2954 |
| 近三年 | 21.73% | 1412/2253 |
| 成立以来 | 60.87% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-0.39% 1779/4961 |
6.96% 2775/5312 |
- - |
- - |
| 2025 | 11.60% 2739/4813 |
0.59% 1810/3635 |
2.38% 1610/4076 |
6.30% 3534/4524 |
1.94% 1140/4813 |
| 2024 | 15.13% 963/3463 |
2.51% 765/2808 |
-0.97% 880/3014 |
14.73% 1920/3129 |
-1.15% 1602/3463 |
| 2023 | -2.42% 579/2656 |
4.98% 847/2280 |
-1.77% 527/2385 |
-1.22% 495/2515 |
-4.21% 914/2655 |
| 2022 | -12.61% 292/2207 |
-9.77% 343/1919 |
3.46% 1149/2016 |
-9.97% 331/2113 |
3.98% 611/2208 |
| 2021 | -2.81% 871/1822 |
-1.05% 424/1255 |
1.99% 1022/1330 |
-8.12% 1103/1466 |
4.82% 312/1822 |
| 2020 | 30.90% 514/1250 |
-7.46% 546/1028 |
13.91% 584/1067 |
10.43% 554/1164 |
12.45% 466/1184 |
| 2019 | - - |
- - |
1.47% 124/788 |
1.96% 341/850 |
9.37% 229/918 |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 万家中证港股通创新药ETF | 1.5896 | 28.31% |
| 港股医疗ETF | 1.4282 | 28.15% |
| 天弘恒生沪深港创新药精选50ETF | 0.8437 | 27.35% |
| 华富中证港股通创新药指数型发起式A | 1.1464 | 27.24% |
| 嘉实中证港股通创新药指数发起式C | 0.8441 | 26.80% |
| 中欧中证港股通创新药指数发起A | 1.5868 | 26.75% |
| 中欧中证港股通创新药指数发起C | 1.4370 | 26.67% |
| 永赢中证港股通医疗主题ETF发起联接A | 0.8762 | 26.58% |
| 华夏中证港股通医疗主题ETF发起式联接A | 0.8585 | 26.45% |
| 华夏中证港股通医疗主题ETF发起式联接C | 0.8568 | 26.39% |
| 国联央视财经50ETF联接A VS. 长安沪深300非周期A(740101) |